US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 11.640
  • +0.100+0.87%
Close Apr 26 16:00 ET
  • 11.400
  • -0.240-2.06%
Post 19:59 ET
3.25BMarket Cap-6158P/E (TTM)

Iovance Biotherapeutics Key Stats

Iovance Biotherapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 28, 2024

Revenue(YoY)

482.00K

0.00%
EPS(YoY)

-0.45

+29.69%

Strong Buy

Mar 31, 2024

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 30.467M--
--2024/Q1-- / 2.088M--
Feb 28, 20242023/Q4482.000K / 1.399M--
Nov 7, 20232023/Q3469.000K / 4.886M--
Aug 8, 20232023/Q2238.000K / 5.375M--
May 9, 20232023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 4, 20222022/Q20.000 / 0.000--
May 5, 20222022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 30.467M--
--2024/Q1-- / 2.088M--
Feb 28, 20242023/Q4482.000K / 1.399M--
Nov 7, 20232023/Q3469.000K / 4.886M--
Aug 8, 20232023/Q2238.000K / 5.375M--
May 9, 20232023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 4, 20222022/Q20.000 / 0.000--
May 5, 20222022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg